Allspring Global Investments’s Roivant Sciences ROIV Stock Holding History

Allspring Global Investments’s Portfolio ROIV Stock Details ROIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.59M	Sell	102,576 -39,558	-28%	-$1.17M	0.01%	954
2026 Q1	$3.96M	Buy	+142,134	New	+$3.65M	0.01%	909
2025 Q1	–	Sell	-14,951	Closed	-$181K	–	1808
2024 Q4	$181K	Buy	14,951 +14	+0.1%	+$166	﹤0.01%	1682
2024 Q3	$172K	Sell	14,937 -115,694	-89%	-$1.32M	﹤0.01%	1704
2024 Q2	$1.38M	Buy	130,631 +60,221	+86%	+$660K	﹤0.01%	1260
2024 Q1	$742K	Buy	70,410 +65,025	+1,208%	+$701K	﹤0.01%	1437
2023 Q4	$60.5K	Buy	5,385 +1,608	+43%	+$15.7K	﹤0.01%	1864
2023 Q3	$44.1K	Buy	+3,777	New	+$42.7K	﹤0.01%	2309

Other funds holding ROIV

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Allspring Global Investments's ROIV Position: Q2 2026 in Review

Allspring Global Investments reduced its Roivant Sciences (ROIV) stake by 28% in Q2 2026, selling an estimated $1.17M and leaving 102,576 shares worth $3.59M. The position accounts for 0.01% of the portfolio, ranked #954.

Allspring Global Investments first reported a position in ROIV in Q3 2023 and has held it in 8 quarters since. The position peaked at $3.96M in Q1 2026. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

Allspring Global Investments held 102,576 shares of Roivant Sciences worth $3.59M as of Q2 2026.
Allspring Global Investments sold 39,558 Roivant Sciences shares in Q2 2026, an estimated $1.17M.
Roivant Sciences made up 0.01% of Allspring Global Investments's portfolio in Q2 2026, its #954 holding.
Allspring Global Investments first reported a position in Roivant Sciences in Q3 2023 and has held it in 8 quarters since.
Allspring Global Investments's Roivant Sciences position peaked at $3.96M in Q1 2026.
498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.